Skip to main content

Table 2 Effectiveness outcomes

From: A randomized matched-pairs study of feasibility, acceptability, and effectiveness of systems consultation: a novel implementation strategy for adopting clinical guidelines for Opioid prescribing in primary care

Through 6 months (Effectiveness)

Baseline value—control clinics

Slope of control clinics (95% CI)

p value (pre-post within control clinics)

Baseline value—intervention clinics

Slope of intervention clinics (95% CI)

p value (pre-post within intervention clinics)

Slope of intervention minus control (95% CI)

p value (difference between intervention—control groups)

Proportion of patients with consistent opioid Rx a

0.014

− 0.0001 (0.0000, − 0.00002)

0.152

0.013

− 0.0002 (− 0.0001, − 0.0003)

0.011

− 0.0001 (0.0000, − 0.0002)

0.237

Proportion with mental health screen b

0.220

0.029 (0.052, 0.006)

0.020

0.226

0.058 (0.079, 0.038)

0.009

0.029 (0.053, 0.005)

0.024

Proportion with urine drug testing b

0.374

0.011 (0.035, − 0.013)

0.025

0.399

0.041 (0.061, 0.020)

0.009

0.029 (0.050, 0.008)

0.011

Proportion with treatment agreement b

0.368

0.029 (0.050, 0.009)

0.009

0.428

0.059 (0.080, 0.038)

0.010

0.03 (0.051, 0.008)

0.012

Average morphine- equivalent daily dose (MEDD) b

58.8

0.245 (−2.08, 2.57)

0.646

86.3

−0.337 (1.07, −1.75)

0.449

−0.581 (0.75, − 1.92)

0.425

Proportion with MEDD > 120 b

0.137

− 0.002 (− 0.001, − 0.004)

0.249

0.215

−0.004 (− 0.002, − 0.005)

0.045

−0.001 (0.003, − 0.006)

0.624

Proportion with co-prescribed benzodiazepines b

0.055

0.001 (− 0.006, 0.008)

0.654

0.080

− 0.001 (0.006, − 0.007)

0.637

− 0.002 (0.000, − 0.003)

0.019

  1. aThree or more opioid prescriptions in each of the most recent 3 months
  2. bSubset of proportion a above (patients with three or more opioid prescriptions in each of the most recent 3 months)
  3. cMEDD morphine-equivalent daily dose (for patients with consistent opioid Rx)